Several studies have proposed that patients with AML with RUNX1::RUNX1T1 as well as KIT mutation [9], particularly KIT exon 17 mutation, have worse clinical outcomes [10, 11]. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.